Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites by Romero Gómez, Manuel et al.
Ontanilla-Clavijo G, Ampuero J, Borreguero S, Rosell J, Romero-Gómez M. 
Usefulness of bioelectrical impedance analysis for monitoring patients with 
refractory ascites. Rev Esp Enferm Dig 2019;111(3):223-227.
DOI: 10.17235/reed.2018.5634/2018
Usefulness of bioelectrical impedance analysis for monitoring patients 
with refractory ascites
ORIGINAL PAPERS
Guillermo Ontanilla-Clavijo1, Javier Ampuero3,4, Samuel Borreguero5, Javier Rosell6 and Manuel Romero-Gómez1,2,3,4
1Digestive Diseases Unit. Hospital Universitario Virgen del Rocío. Sevilla, Spain. 2Instituto de Biomedicina de Sevilla. Sevilla, Spain. 3CIBERehd. 
Sevilla, Spain. 4Universidad de Sevilla. Sevilla, Spain. 5Talemnology S.L. San Juan de Aznalfarache. Sevilla, Spain. 6Univesidad Politécnica de 
Catalunya. Barcelona, Spain
Received: 28/04/2018 · Accepted: 20/10/2018
Correspondence: Javier Ampuero. Digestive Diseases Unit. Hospital Universitario Virgen del Rocío. Av. Manuel 
Siurot, s/n. 410013. Sevilla, Spain. e-mail: jampuero-ibis@us.es
ABSTRACT
Background: bioelectrical impedance analysis is a tech-
nique for the determination of the hydropic component. The 
hydropic component, determined by blood volume, could 
be a reflection of the hemodynamic situation. This study 
aimed to evaluate the usefulness of peripheral bioelectrical 
impedance analysis (BIA) for the prediction of hemodynam-
ic changes in large-volume paracentesis and prognosis.
Methods: this was a proof-of-concept prospective study of 
14 patients with liver cirrhosis and refractory ascites. Pe-
ripheral bioimpedance was measured three times using a 
portable device, IVOL®, before and after large-volume para-
centesis, at different frequencies (5, 10, 20, 50, 100 and 200 
kHz). Consequently, resistance, reactance and phase angle 
were obtained, both pre- and post-paracentesis (the differ-
ence between them was defined as Δ).
Results: the mean age of patients was 62.2 ± 9.6 years, the 
Child-Pugh was 8.4 ± 1.3 and the MELD score was 15.2 ± 3.9. 
A direct correlation between the extraction of ascitic fluid 
and Δresistance (10 kHz [r = 0.722; n = 12; p = 0.008], 20 kHz 
[r = 0.658; n = 12; p = 0.020] and 50 kHz [r = 0.519; n = 14; p 
= 0.057]) was observed. The presence of edema was related 
to lower values of both pre-paracentesis resistance (10 Hz 
[23.9 ± 8 vs 32.2 ± 4; p = 0.043]) and phase angle (5 kHz [-1.9 
± 2.8 vs 5.9 ± 7.3; p = 0.032]). Pre-paracentesis phase angle 
was directly correlated with the decline in blood pressure 
after paracentesis at lower frequencies (5 kHz [r = 0.694; n 
= 13; p = 0.008] and 10 kHz [r = 0.661; n = 13; p = 0.014]). 
Lower frequencies of Δphase-angle impacted on patient 
prognosis (5 kHz [-8.6 ± 5 vs -2.5 ± 2.7; p = 0.021]), patients 
with Δphase-angle 5 kHz > -4 had a higher rate of mortality 
(83.3% [5/6] vs 0% [0/6]; logRank 7.306, p = 0.007). Δresis-
tance values were associated with overt HE at six months 
(10 kHz [4.9 ± 2.5 vs -0.4 ± 4.7; p = 0.046]).
Conclusions: in conclusion, a significant correlation be-
tween peripheral impedance and hemodynamic changes 
was found. Impedance was also significantly related to 
prognosis and overt hepatic encephalopathy. 
Key words: Cirrhosis. Refractory ascites. Bioelectrical anal-
ysis. Bioimpedance. Paracentesis. 
INTRODUCTION
Patients with liver cirrhosis frequently develop a hyper-
dynamic circulation (1), which is characterized by a fall 
in peripheral vascular resistance and a compensatory 
increase in cardiac output (2). Hemodynamic alterations 
may eventually result in acute (hepatorenal syndrome) or 
chronic complications (refractory ascites) (3,4). In addition, 
paracentesis-induced circulatory dysfunction (PICD) is a 
well-documented risk for hemodynamic dysbalance in cir-
rhotic patients, especially those that require periodically 
large volume paracentesis (4). Different methods are used 
to evaluate hemodynamic parameters in cirrhotic patients, 
from invasive (based on transpulmonary thermodilution 
that is reserved for critical patients) to non-invasive tech-
niques (such as transthoracic echocardiography) (5,6).
Bioelectrical impedance analysis (BIA) is a simple technique 
for the determination of body water and body composi-
tion (7). This technique obtains measurements such as re-
sistance (R) and reactance (Xc). The combination of these 
parameters is used to calculate the phase angle (PA), which 
is directly related to the composition of the tissues and the 
presence of intra and extracellular water (8,9). These val-
ues can be determined at a single frequency (SF-BIA) or 
multiple frequency (MF-BIA). MF-BIA has been shown to 
be more accurate for the determination of total body water 
(TBW) and extracellular fluid (ECF) (10). The hydropic com-
ponent is determined by blood volume and could therefore 
be a reflection of the hemodynamic situation. In fact, it has 
been demonstrated that patients with decompensated have 
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a greater amount of extracellular water in the limbs com-
pared to compensated cirrhotics (11). PA, which is the most 
established BIA parameter for the diagnosis of malnutrition 
and clinical prognosis, is based on changes in cellular mem-
brane integrity and alterations in fluid balance. For instance, 
PA has been associated with mortality in cirrhotic patients 
by a whole-body BIA at 50 kHz (12-14).
Due to the marked alteration in the intra- and extravascular 
hydropic component in patients with cirrhosis and refrac-
tory ascites, this study aimed to evaluate the usefulness of 
peripheral BIA for the prediction of hemodynamic changes 
in large-volume paracentesis. Furthermore, its relation to 
the incidence of cirrhosis complications and survival was 
also assessed.
METHODS
Study design
This was a prospective proof-of-concept study of 14 pa-
tients with liver cirrhosis and refractory ascites. Patients 
were enrolled in 2016, at the time of the first BIA and fol-
lowed over a twelve month period. Refractory ascites were 
defined as ascites that cannot be mobilized with diuretics or 
early recurrence which cannot be satisfactorily prevented 
by medical therapy due to side effects, as established by 
the International Club of Ascitis. Therefore, all patients were 
on a periodic large-volume paracentesis program followed 
by an intravenous infusion of albumin (6-8 g/l of ascites 
removed) from 5 l extracted (4). None of the patients were 
candidates for a liver transplantation and no other causes 
of ascites, such as cardiac or renal insufficiency, were found 
in these patients. 
Demographic and anthropometric characteristics, as well as 
salt and alcohol consumption, were analyzed. The etiology 
of cirrhosis and treatment with diuretics and beta-blockers 
were also recorded. Furthermore, the presence of periph-
eral edema or venous insufficiency in the lower limbs were 
recorded, discarding the presence of spontaneous bacterial 
peritonitis in all patients. Liver function was assessed using 
the Child-Pugh scale and the MELD score. The time from 
the first documented episode of ascites and the time that 
large-volume paracentesis was required were also taken 
into account. 
All patients provided written informed consent and all data 
(including clinical, demographic and test results) were cod-
ed and deposited in the original clinical database. The Ethics 
Committee of the Hospital Universitario Virgen del Rocío 
approved the protocol and it was extended to the rest of 
participating centers. The study was conducted according 
to the ethical guidelines of the Declaration of Helsinki and 
International Conference on Harmonization Guidelines for 
Good Clinical Practice.
BIA assessment
Peripheral bioimpedance was measured using a portable 
device, IVOL® (Talemnology S.L., San Juan de Aznalfarache, 
Sevilla, Spain). Measurements were obtained in a supine 
position by applying a low-intensity electric current be-
tween two pairs of electrodes, which were placed vertical-
ly on the outer side of the right lower limb, 2 cm above 
the external epicondyle of the ankle. Three measurements 
were performed, before and after paracentesis, at different 
frequencies (5, 10, 20, 50, 100 and 200 kHz). The mean value 
was used as the definitive result. Consequently, resistance 
(R), reactance (Xc) and phase angle (PA) were obtained, 
both pre- and post-paracentesis (the difference between 
them was defined as Δ).
Assessment of outcome
All the results were divided into two groups, those relat-
ed to paracentesis and those related to cirrhosis compli-
cations. Blood pressure (including systolic, diastolic and 
mean arterial pressure) and heart rate were determined 
three times, before and four hours after the paracentesis 
(the difference between them was defined as Δ) in order 
to establish the potential impact of the magnitude of the 
changes in body homeostasis. The mean values of pre and 
post-paracentesis measures were taken into account for 
the analysis. The volume of fluid extracted and replacement 
with albumin were recorded; the presence of spontaneous 
bacterial peritonitis (SBP) was routinely ruled out. The fol-
lowing laboratory parameters were collected the day of 
paracentesis: total bilirubin, international normalized ratio 
(INR), creatinine, alanine transaminase (ALT), cholinester-
ase, albumin, platelets and sodium.
Furthermore, cirrhosis outcome was collected during fol-
low-up, including hepatic encephalopathy (HE), variceal 
bleeding, SBP, kidney failure and hepatocellular carcino-
ma. All events were classified as short- (occurring within 
six months) or long-term (occurring within twelve months) 
depending on the time of appearance. Thus, patients were 
followed-up for a period of twelve months or until death. 
Statistical analysis
Statistical analysis was performed by a biomedical statisti-
cian using SPSS (version 21.0; SPSS, Inc., Chicago, IL). The 
Chi-square test and the Fisher’s exact test (F) when necessary 
were used for qualitative variables. The Student’s t-test (t) 
was used when the distribution was normal for quantitative 
variables and the Mann-Whitney U test was used when the 
distribution was non-normal. The association between differ-
ent quantitative variables was evaluated using the Pearson’s 
or Spearman’s correlation. The area under the ROC curve 
(AUROC) was computed in order to determine the diagnostic 
accuracy of the BIA measurements for predicting mortali-
ty. Survival curves were compared using the Kaplan-Meier 
method (log-rank test), as time-to-mortality and time-to-
event are crucial for interpreting the results. Statistical sig-
nificance was set at p < 0.05. The statistical methods of this 
study were reviewed by the corresponding author.
RESULTS
Baseline features of the overall cohort
Ninety percent (13/14) of the patients were male, with a 
mean age of 62.2 ± 9.6 years. Child-Pugh was 8.4 ± 1.3 and 
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the MELD score was 15.2 ± 3.9. The main etiology was al-
coholic cirrhosis (78% [11/14]) and 14% (2/14) and 7% (1/14) 
of patients suffered from chronic HCV and HBV infection, 
respectively. With regard to cirrhosis-related complications, 
all patients had esophageal varices, 64% (9/14) had experi-
enced a prior episode of variceal bleeding and one patient 
had a previous history of SBP and hepatorenal syndrome; 
42% (6/14) of the overall cohort had hepatocellular carcino-
ma. With regard to treatment, half of the patients consumed 
diuretics (57% [8/14]) and 35% (5/14) used beta-blockers. 
Alcohol consumption was unusual (7% [1/14]), although salt 
intake was common (85% [12/14]). At enrollment, patients 
had required large-volume paracentesis for ten months (1-
56), with a median interval of time between treatments of 
13.4 ± 4.9 days. The mean volume of ascites fluid extracted 
was 8.4 ± 4 liters.
The role of peripheral BIA during the paracentesis
In the overall population, significant differences were found 
between pre- and post-paracentesis measurements accord-
ing to PA at lower frequencies (Table 1). Furthermore, a 
direct correlation was observed between the extraction of 
ascitic fluid and ΔR (10 kHz [r = 0.722; n = 12; p = 0.008], 
20 kHz [r = 0.658; n = 12; p = 0.020] and 50 kHz [r = 0.519; 
n = 14; p = 0.057]). The presence of edema was related to 
lower values of both pre-paracentesis R (10 kHz [23.9 ± 8 
vs 32.2 ± 4; p = 0.043]) and PA (5 kHz [-1.9 ± 2.8 vs 5.9 ± 
7.3; p = 0.032]) (Fig. 1). However, neither ΔR nor ΔPA were 
influenced by the presence of edema. On the other hand, 
both salt consumption and diuretic use did not impact on 
the BIA measurements. Post-paracentesis R values at all 
frequencies were related with the number of days since the 
previous paracentesis. However, all of these measurements 
were not associated with the time interval to the subse-
quent paracentesis requirement.
The role of peripheral BIA and hemodynamic changes
The mean arterial pressure before paracentesis was 91 ± 12 
mmHg and the final value after was 81 ± 10 mmHg (-10 ± 9 
mmHg; p = 0.001). In contrast, the heart rate did not show 
significant differences; pre-paracentesis 82 ± 14 vs 83 ± 12 
bpm (p = 0.807). Pre-paracentesis PA was directly correlated 
with a decline of blood pressure after paracentesis at lower 
frequencies (5 kHz [r = 0.694; n = 13; p = 0.008] and 10 kHz 
[r = 0.661; n = 13; p = 0.014]). In fact, 88.9% (8/9) of patients 
with a pre-paracentesis PA 5 kHz of < 5 suffered from a 
significant drop of at least 7 mmHg in the mean arterial 
pressure after paracentesis (Fig. 2). In addition, there was 
a trend with the variation in cardiac frequency (5 kHz [r = 
0.493; n = 13; p = 0.087] and 10 kHz [r = 0.490; n = 13; p = 
0.089]). There was no correlation between ΔPA and ΔTA, 
probably due to the fact that patients with preparacentesis 
PA values > 5 did not show a significant drop in mean ar-
terial pressure. Furthermore, the small number of patients 
included in the study meant that this correlation could not 
be demonstrated. 
Prognostic value of peripheral BIA
There were nine episodes of overt HE during follow-up, 
five events of acute kidney injury, three episodes of SBP 
(two also suffered a variceal bleed) and one event of vari-
ceal bleeding and hepatorenal syndrome. In addition, sev-
en patients died within 12 months of follow-up, all due to 
complications derived from their liver disease. 
One-year survival was influenced by BIA measurements. In 
particular, lower frequencies of ΔPA impacted on the prog-
nosis of the patients (5 kHz [-8.6 ± 5 vs -2.5 ± 2.7; p = 0.021] 
Table 1. Dynamic changes of PA during the paracentesis
PA frequency
Pre-
paracentesis
Post-
paracentesis
Univariable 
analysis
5 Hz 2.28 ± 6.80 -2.16 ± 2.34 p = 0.004
10 Hz -1.02 ± 2.04 -3.23 ± 1.32 p = 0.002
20 Hz -3.21 ± 1.29 -4.64 ± 1.79 p = 0.006
50 Hz -5.80 ± 1.59 -6.44 ± 1.75 p = 0.254
100 Hz -7.41 ± 1.54 -7.32 ± 1.50 p = 0.278
200 Hz -9.46 ± 1.60 -8.70 ± 1.69 p = 0.139
Fig. 1. Pre-paracentesis PA 5 kHz value depending on the 
presence of edema.
Fig. 2. Relation between PA 5 Hz value and arterial 
pressure after paracentesis.
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and 10 kHz [-3.6 ± 2.2 vs -1.4 ± 1.3; p = 0.052]). According 
to ROC analysis (AUROC 0.91 [95%CI 0.74-1.00]; p = 0.019), 
those patients with ΔPA 5 kHz > -4 had a higher mortali-
ty rate (83.3% [5/6] vs 0% [0/6]; log rank 7.306, p = 0.007) 
(Fig. 3). The remaining outcomes, including all cirrhosis 
complications, were not influenced at 12 months by BIA 
measurements. However, ΔR values were associated with 
overt HE at six months (10 kHz [4.9 ± 2.5 vs -0.4 ± 4.7; p = 
0.046]). In contrast, other complications, including survival, 
were not linked to BIA measurements during the short-term 
follow-up. 
DISCUSSION
BIA has been evaluated in the cirrhotic population in many 
studies, although there is a lot of heterogeneity due to sev-
eral reasons: a) the frequency used (single-frequency vs 
multi-frequency analysis); b) the type of BIA (whole-body vs 
segmental analysis); and c) the aim, as most studies were 
performed to detect nutritional deficiencies in liver diseases 
(15,16), although other studies aimed to assess the poten-
tial utility for predicting prognosis and cirrhosis outcome 
(17). On the other hand, monitoring the hemodynamic sta-
tus of decompensated cirrhotic patients is underused, due 
to inaccessibility and cost (i.e., echocardiography). Thus, 
the evaluation is based on the blood pressure (including 
systolic, diastolic and mean blood pressure) and heart rate, 
which grossly reflect the cardiovascular unbalance in these 
patients. However, they are not useful in situations of se-
vere decompensation, such as refractory ascites (18). Based 
on the evidence compiled, we conducted a pilot study in 
patients with refractory ascites to assess the applicabili-
ty peripheral and multi-frequency BIA measurements on 
paracentesis-related hemodynamic changes and prognosis.
Decompensated cirrhotic patients with refractory ascites 
can be exposed to paracentesis-induced circulatory dys-
function (PICD) after a large-volume paracentesis. This is 
definitively diagnosed via laboratory results, with increases 
of more than 50% of baseline plasma renin activity to > 4 ng/
ml/h on the 5th to 6th days after paracentesis. Therefore, early 
detection and treatment of PICD are essential to decrease 
the paracentesis-related mortality and morbidity (19). The 
management of PICD is standardized, including the infu-
sion of albumin to prevent the risk of renal impairment and 
mortality by preventing systemic hemodynamic alterations 
(20). In addition, other drugs have been tested such as mi-
dodrine (21) or terlipressin (22) . However, there is little 
information about how to anticipate PICD and its prognosis 
with non-invasive tests. In this study, we found a significant 
correlation between peripheral BIA (pre-paracentesis PA at 
5 and 10 kHz) and hemodynamic changes, including mean 
blood pressure and cardiac frequency. However, we did 
not determine the values of plasma renin activity in order 
to reliably establish the PICD diagnosis. This was mainly 
due to the lack of financial support, and these hemody-
namic changes occur at the beginning of the cascade of 
deleterious effects caused by large-volume paracentesis 
(LVP), which in some cases will end in PICD. In particular, 
most of the patients (89%) with a pre-paracentesis PA 5 kHz 
lower than 5 showed a consistent decrease in mean arte-
rial pressure. Pre-paracentesis measurements are highly 
relevant as they could allow the prediction of the risk of 
PICD before starting the procedure. For instance, it could 
help to determine how many liters of ascitic fluid should 
be evacuated in order to prevent paracentesis-related com-
plications. Further research is needed to properly establish 
the relationship of this measure with PICD. However, the 
results extracted from this study open a new door in the 
management of patients with refractory ascites.
Decompensated cirrhotic patients with refractory ascites in 
a large-volume paracentesis program have a poor progno-
sis (up to 50% of 1-year mortality) if they do not undergo 
liver transplantation (23). Therefore, clinicians need non-in-
vasive tools that can predict short- and mid-term prognosis 
in this population. In this setting, we found that ΔPA at low-
er frequencies (5 kHz and 10 kHz) was related to mortality 
within 12 months of follow-up. In particular, there were no 
fatal events in patients with ΔPA 5 kHz < -4. In addition, ΔR 
was able to predict overt hepatic encephalopathy within six 
months. Therefore, the peripheral BIA measurement could 
help, not only to decrease the risk of paracentesis-related 
outcomes but also to predict some cirrhosis-related com-
plications.
This study was designed as a prospective proof-of-concept 
study. Therefore, a limited sample size was included and, 
consequently, our conclusions must be validated in larger 
populations. In addition, some circumstances (peripheral 
edema) could result in variations in BIA values in cirrhotic 
patients. Therefore, a subgroup analysis will probably be 
needed. Furthermore, the results regarding the prognostic 
value of the device must be carefully considered as almost 
half of the population of the study (42%) had hepatocarcino-
ma at the time of inclusion. This condition deeply influences 
the survival of these patients. In contrast, this study had 
several strengths. First, the BIA measurement included a 
multi-frequency analysis that was not frequent in previous 
studies. Particularly, lower frequencies (5 and 10 kHz) influ-
enced the outcome much more than higher values (data 
not shown, apart from table 1). This is a relevant issue as 
the majority of the studies of BIA in cirrhotic patients were 
performed with a frequency of 50 kHz (12-16,24,25). Sec-
ond, the peripheral BIA measurement (based on a small 
and portable device) is a quick and bedside test which can 
be used easily and repeatedly, both in the outpatient clinic 
and during hospitalization.
Fig. 3. Kaplan-Meier survival curve at one year according 
to the ΔPA 5 kHz value.
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Peripheral BIA measurements, particularly PA at lower 
frequencies, is a simple and quick bedside test that pro-
vides useful information for the management of patients 
with refractory ascites. This technique could lead to a safer 
large-volume paracentesis and determine a subgroup of 
patients at risk of short-term hepatic encephalopathy and 
death.
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